Patent ID: 9527891
Filing Date: 2016-12-27
CPC Classification: A61K,A61P,C07K

Claim Text:
1. An immunoadjuvant compound comprising: a) a N-terminal peptide having at least 95% amino acid identity with the amino acid sequence starting from the amino acid residue located at position 1 of SEQ ID No 1 and ending at an amino acid residue selected from the group consisting of any one of the amino acid residues located at positions 99 to 173 of SEQ ID No 1; and b) a C-terminal peptide, wherein the said C-terminal peptide is selected from the group consisting of the amino acid sequences 401-494 and 406-494 of SEQ ID NO1, wherein: the said N-terminal peptide is linked to the said C-terminal peptide one to the other, through a spacer chain, the spacer chain consisting of 1 to 20 amino acids linked by peptide bonds, wherein the amino acids are selected from the 20 naturally-occurring amino acids and wherein (i) the said N-terminal and C-terminal peptides consist of the amino acid sequences 1-137 and 406-494 of SEQ ID No 1, respectively; or (ii) said N-terminal peptide and the said C-terminal peptide are indirectly linked, one to the other, through an intermediate spacer chain consisting of NH